InnoCare Pharma Limited
諾誠健華醫藥有限公司
(Incorporated in the Cayman Islands with limited liability)
（於開曼群島註冊成立的有限公司）
(Stock code 股份代號 : 9969)
1 March 2024
Dear non-registered shareholder(s),
Arrangement of Electronic Dissemination of Corporate Communications
Introduction
Pursuant to Rule 2.07 of the Rules Governing The Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”) under the expansion
of paperless listing regime and electronic dissemination of corporate communications that came into effect on 31 December 2023, InnoCare Pharma Limited (the
“Company”) is writing to inform you that the Company has adopted electronic dissemination of future corporate communications (the “Corporate
Communications”) (Note1) to its shareholders (the “Shareholders”) and will only send Corporate Communications in printed form to its shareholders upon request.
The Company will make available electronically both the English and Chinese versions of all Corporate Communications on its website (www.innocarepharma.com)
and the Stock Exchange’s website (www.hkexnews.hk) (the “Website Version”) in place of printed copies.
However, subject to Shareholders’ approval, until the Company has amended its articles of association, which is expected to take place at the annual general meeting
proposed to be convened in June 2024, a notice of publication of the Website Version of Corporate Communications, in both English and Chinese, will be sent by
the Company to Shareholders by email or by post (if in the case the Company does not possess a functional email address of a Shareholder) on the publication date
of the Corporate Communications.
As a non-registered shareholder, if you want to receive a notice of publication of the Website Version of Corporate Communications (if any) by email, you
should liaise with your bank(s), broker(s), custodian(s), nominee(s) or HKSCC Nominees Limited through which your Shares are held (collectively, the
“Intermediaries”) and provide your email address to your Intermediaries.
Request for Corporate Communications in printed form
If you want to receive the Corporate Communications in printed form, please complete and return the Reply Form on the reverse side to the Company’s Hong Kong
share registrar (the “Share Registrar”), Computershare Hong Kong Investor Services Limited or send an email to InnoCare.ecom@computershare.com.hk
specifying your name, address and request to receive the Corporate Communications in printed form.
Should you have any queries relating to this letter, please contact the Share Registrar at (852)2862 8688 during business hours from 9:00 a.m. to 6:00 p.m. (Hong
Kong time), Mondays to Fridays, excluding Hong Kong public holidays.
By order of the Board
InnoCare Pharma Limited
Dr. Jisong Cui
Chairperson and Executive Director
Note: Corporate Communications include any documents issued or to be issued by the Company, including but not limited to (a) the directors’ report, its annual
accounts together with a copy of the auditors’ report and, where applicable, its summary financial report; (b) the interim report and, where applicable, its summary
interim report; (c) a notice of meeting; (d) a listing document; (e) a circular and (f) a proxy form.
各位非登記股東：
以電子方式發布公司通訊之安排
簡介
根據自 2023 年 12 月 31 日起生效的擴大無紙化上市機制及以電子方式發布公司通訊規定下香港聯合交易所有限公司證券上市規則（「上市規則」）第
2.07 條，諾誠健華醫藥有限公司（「公司」）謹此通知 閣下，本公司將以電子通訊方式向其股東（「股東」）發佈本公司日後的公司通訊（「公司通
訊」）（附註 1），並僅應股東要求向其寄發印刷本形式的公司通訊。
本公司將在本公司網站（www.innocarepharma.com）及聯交所網站（www.hkexnews.hk）上發佈公司通訊（「網上版本」）。
然而，本公司擬於 2024 年 6 月舉行的股東週年大會上修訂其章程，其修訂須通過股東批准，在修訂章程之前，本公司將於公司通訊刊發日期通過電子
郵件方式或郵寄方式（在本公司沒有獲取股東有效電子郵箱地址時） 向股東發送公司通訊網上版本的登載通知，該通知將同時提供英文和中文版本。
作為非登記股東，若 閣下希望收取公司通訊網上版本的登載通知， 閣下應聯絡代 閣下持有股份的銀行、經紀、託管商、代理人或香港中央結算
（代理人）有限公司（統稱「中介公司」），並向 閣下的中介公司提供 閣下的電子郵件地址。
索取企業通訊的印刷本
若 閣下希望收取公司通訊之印刷版，請填妥本函背頁之回條並交回香港股份過戶登記處（「股份過戶處」）香港中央證券登記有限公司，或發送電子
郵件至 InnoCare.ecom@computershare.com.hk，並註明 閣下的姓名、地址以及收取公司通訊印刷版的要求。
如 閣下對本函件有任何疑問，請於辦公時間星期一至五（香港公眾假期除外）上午 9 時正至下午 6 時正（香港時間）其間致電股份過戶處(852)2862
8688 查詢。
承董事會命
諾誠健華醫藥有限公司
主席兼執行董事
崔霽松博士
2024 年 3 月 1 日
附註:公司通訊包括本公司發佈或將要發布的任何文件，其中包括但不限於 (a) 董事報告、年度帳目以及審計報告副本以及（如適用）財務摘要報
告； (b) 中期報告及其中期報告摘要（如適用）； (c) 會議通知； (d) 上市文件； (e) 通函和 (f) 委任表格。
CCS7714 IPLH _NRH
REPLY FORM 回條
To: Computershare Hong Kong Investor Services Limited 致： 香港中央證券登記有限公司
(The “Share Registrar”) （「股份過戶處」）
17M Floor, Hopewell Centre, 香港灣仔皇后大道東 183 號
183 Queen’s Road East, Wanchai, Hong Kong 合和中心 17M 樓
REMINDER 提示
As a non-registered shareholder, you should liaise with your bank(s), broker(s), custodian(s), nominee(s) or HKSCC Nominees Limited
through which your shares are held (collectively, the “Intermediaries”) and provide your email address to your Intermediaries.
作為非登記股東， 閣下應聯絡 閣下持有股份的銀行、經紀、託管商、代理人或香港中央結算（代理人）有限公司（統稱「中介公
司」），並向 閣下的中介公司提供 閣下的電子郵件地址。
Request for Corporate Communications* in printed form / 要 求 收 取 公 司 通 訊 * 印 刷 版
(Please mark “” in the below box if applicable)（如適用，請在以下方格內劃上「」號）
Name of the listed company (the “Company”) : InnoCare Pharma Limited
上市公司（「公司」）名稱： 諾誠健華醫藥有限公司
I/we would like to receive future Corporate Communications* in printed form.
*
本人 ╱ 我們欲收取未來公司通訊 的印刷版。
Printed English version 英文印刷本 Printed Chinese version 中文印刷本 Printed English and Chinese versions 中、英文印刷本
(Note 3)
Name(s) of Non-registered holder(s): Signature(s):
非登記股東姓名： 簽名： (附註 3)
(Please use ENGLISH BLOCK LETTERS 請用英文正楷填寫)
Contact number: Date:
聯絡電話號碼： 日期：
Notes:
附註：
1. This Reply Form is addressed to non-registered holder(s) (“Non-registered holder” means such person or company whose shares are held in The Central Clearing and Settlement System (CCASS)
and who has notified the Company from time to time through Hong Kong Securities Clearing Company Limited that such person or company wishes to receive Corporate Communications*).
此回條乃向本公司之非登記股東（「非登記股東」指股份存放於中央結算及交收系統的人士或公司，已透過香港中央結算有限公司不時向本公司發出通知，表示欲收取公司通訊 *）發
出。
2. Please complete all your details clearly.
請 閣下清楚填妥所有資料。
3. Any form with no box marked (), with no signature or otherwise incorrectly completed will be void.
如在本表格未有在方格內劃上「 」號、或未有簽署、或在其他方面填寫不正確，則本表格將會作廢。
4. For the avoidance of doubt, the Company does not accept any other instructions given on this Reply Form.
為免存疑，在本回條上的任何額外指示，公司將不予處理。
* Unless otherwise specified, Corporate Communications refer to any documents issued or to be issued by the Company for the information or action of holders of any of its securities, including
but not limited to the annual report, interim report, notice of meeting, circular and proxy form.
除非另有註明，公司通訊乃指公司已發出或將予發出以供其任何證券的持有人參照或採取行動的任何文件，其中包括但不限於年報、中期報告、會議通告、通函及代表委任表格。
PERSONAL INFORMATION COLLECTION STATEMENT
收集個人資料聲明
(i) “Personal Data” in this statement has the same meaning as “personal data” in the Personal Data (Privacy) Ordinance, Chapter 486 of the Laws of Hong Kong (“PDPO”).
本聲明中所指的「個人資料」與香港法例第 486 章《個人資料（私隱）條例》（「《私隱條例》」）中「個人資料」的涵義相同。
(ii) Your Personal Data provided in this Reply Form will be used in connection with the Company’s electronic dissemination of Corporate Communications. Your supply of Personal Data to the
Company is on a voluntary basis. In case of a failure to provide sufficient information, the Company may not be able to proce ss your instructions and/or requests as stated in this Reply Form.
閣下於本回條所提供的個人資料將用於有關公司以電子方式發布公司通訊的事宜上。 閣下是自願向本公司提供個人資料。若 閣下未能提供足夠資料，本公司可能無法處理 閣下在
本回條上所述的指示及/或要求。
(iii) Your Personal Data may be disclosed or transferred by the Company to its subsidiaries, the Share Registrar, and/or other companies or bodies for any of the stated purposes, or when it is
required to do so by law and will be retained for such period as may be necessary for our verification and record purposes.
公司可就任何所說明的用途或在法例規定的情況下，將 閣下的個人資料披露或轉移給公司的附屬公司、股份過戶處、及/或其他公司或團體，並將在適當期間保留該等個人資料作
核實及紀錄用途。
(iv) You have the right to request access to and/or correction of your Personal Data in accordance with the provisions of th e PDPO. Any such request for access to and/or correction of your
Personal Data should be in writing, by mail to the Hong Kong Privacy Officer of the Share Registrar at 17M Floor, Hopewell Centre, 183 Queen’s Road East, Wanchai, Hong Kong or by
email at PrivacyOfficer@computershare.com.hk.
閣下有權根據《私隱條例》的條文查閱及/或修改 閣下的個人資料。任何該等查閱及/或修改個人資料的要求均須以書面方式郵寄至股份過戶處（地址為香港灣仔皇后大道東 183 號
合和中心 17M 樓）向香港隱私主任提出，或發送電郵至 PrivacyOfficer@computershare.com.hk。
Mailing Label 郵 寄 標 籤
Please cut the mailing label and stick it on an envelope to return this form to us.
Computershare Hong Kong Investor Services Limited No postage is necessary if posted in Hong Kong.
香港中央證券登記有限公司
Freepost No. 簡便回郵號碼：37 當 閣下寄回此回條時，請將郵寄標籤剪貼於信封上。
Hong Kong 香港 如在本港投寄， 閣下無需支付郵費或貼上郵票。
